Results 281 to 290 of about 208,134 (332)

Cardio‐Kidney‐Metabolic Therapy Use Among Adults With Type 1 Diabetes and Chronic Kidney Disease

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4344-4351, May 2026.
ABSTRACT Aims Kidney and cardiovascular diseases are highly prevalent among patients with Type 1 diabetes. To date, no randomised clinical trial has reported on the impact of novel cardio‐kidney‐metabolic (CKM) therapies (GLP‐1RA and SGLT2i) on kidney function in this population.
M. Luiza Caramori   +4 more
wiley   +1 more source

First metagenomic analysis of age-associated changes in the gut microbiome among healthy Saudi adults: SAMS pilot study. [PDF]

open access: yesFront Aging
Almatrafi R   +11 more
europepmc   +1 more source

Two Norms Collide: EU Policy on Fragile and Conflict‐Affected Countries

open access: yesJCMS: Journal of Common Market Studies, Volume 64, Issue 3, Page 1223-1237, May 2026.
Abstract The European Union's (EU's) policy towards fragile and conflict‐affected (FCA) countries has been framed by a normative solidarity narrative that promotes and legitimises collective action. Over the past two decades, the EU's commitment to protecting the security of its citizens has increasingly become a strong, competing normative driver of ...
Julian Bergmann, Mark Furness
wiley   +1 more source

Genetic study in young patients with chronic kidney disease stage G5 from unknown etiology. The GENSEN study design

open access: diamond
Miquel Blasco   +5 more
openalex   +1 more source

Acyclic serinol nucleic acid modification of siRNAs overcomes seed region mediated off-target effects while maintaining potency. [PDF]

open access: yesNucleic Acids Res
Chickering T   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy